ANEB - Anebulo Pharmaceuticals GAAP EPS of -$0.15 misses by $0.04 February, 10 2023 09:40 AM Anebulo Pharmaceuticals Inc. Anebulo Pharmaceuticals press release ( NASDAQ: ANEB ): Q2 GAAP EPS of -$0.15 misses by $0.04 . Cash was $16.4 million as of December 31, 2022. For further details see: Anebulo Pharmaceuticals GAAP EPS of -$0.15 misses by $0.04